Explore the complete record of transactions filed by Ellingson Rachel, Directeur de la Stratégie. Director active across 2 companies, notably Zimmer Biomet Holdings, INC.. In total, 5 filings have been published. The latest transaction was filed on 1 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
5 of 5 declarations
Rachel Ellingson serves as Senior Vice President and Chief Strategy Officer at Zimmer Biomet Holdings, Inc. and Biolife Solutions Inc. She is responsible for developing and implementing corporate strategies aimed at supporting growth and innovation. Rachel has extensive experience in strategic development and operational management, contributing to the achievement of organizational goals. Her role also involves collaborating with other executives to align strategic initiatives with the company's priorities.